Mustafa Alperen Tunç

10PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 15, 2026
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies.

|May 23, 2026
Development and internal validation of the CLIP-M score for advanced mucosal malignant melanoma: exploratory prognostic stratification and comparative assessment with the RMH score.

|Jan 28, 2026
Prognostic Value of Systemic Immune-Inflammation Index in Mucosal Malignant Melanoma.

Burak Paçacı, Erkam Kocaaslan, Ahmet Demirel

|Jan 28, 2026
Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab.

Erkam Kocaaslan, Ali Kaan Güren, Fırat Akagündüz

|Jan 28, 2026
Prognostic Value of Treatment-Related Body Composition Changes in Metastatic NSCLC Receiving Nivolumab.

Erkam Kocaaslan, Ali Kaan Güren, Fırat Akagündüz

|Aug 28, 2025
The Role of Baseline PET/CT Parameters in Predicting Treatment Response in Patients with Locally Advanced Rectal Cancer Undergoing Total Neoadjuvant Therapy.

Ali Kaan Güren, Zilan Başkan, Zeynep Ceren Balaban Genç

Pageof 2

Frequent Collaborators

9 joint publications

Ali Kaan Güren

8 joint publications

Nadiye Sever

8 joint publications

Murat Sarı

8 joint publications

İbrahim Vedat Bayoğu